Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007462
Filing Date
2025-05-13
Accepted
2025-05-12 19:43:33
Documents
105
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20250331x10q.htm   iXBRL 10-Q 1988943
2 EX-31.1 akya-20250331xex31d1.htm EX-31.1 16019
3 EX-31.2 akya-20250331xex31d2.htm EX-31.2 16027
4 EX-32.1 akya-20250331xex32d1.htm EX-32.1 6709
5 EX-32.2 akya-20250331xex32d2.htm EX-32.2 7713
  Complete submission text file 0001558370-25-007462.txt   9833771

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20250331.xsd EX-101.SCH 66517
7 EX-101.CAL akya-20250331_cal.xml EX-101.CAL 85601
8 EX-101.DEF akya-20250331_def.xml EX-101.DEF 267939
9 EX-101.LAB akya-20250331_lab.xml EX-101.LAB 557696
10 EX-101.PRE akya-20250331_pre.xml EX-101.PRE 459767
108 EXTRACTED XBRL INSTANCE DOCUMENT akya-20250331x10q_htm.xml XML 1829366
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 25936665
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)